SCOR Shares Drop 2.19% Despite Target Upgrade from BNP Paribas Exane

Target Price Revision by BNP Paribas Exane

On Wednesday, March 11, BNP Paribas Exane revised its price target on SCOR SE, raising it from 32.00 to 33.00 euros, while maintaining its 'outperform' recommendation. At the current price of 29.50 euros, this new target implies a potential upside of about 11.9%. However, this increase was not enough to support the stock during the session, with the day's decline erasing part of the weekly gain, which remains positive at 1.72% over seven days. Over a broader horizon, the stock has shown a growth of 9.83% over three months and 14.79% over a year, indicating a medium-term upward trajectory. The general assembly is scheduled for April 28, followed by the publication of the first-quarter results on May 6, two events that could provide new insights for investors.

Technical Perspective on the Day's Decline

From a technical viewpoint, the significance of today's decline is highlighted by the resistance level at 30.90 euros. The stock, which was trading at 30.16 euros just the day before, failed to approach this threshold and has returned to its 20-day moving average of 29.57 euros. The 50-day moving average, however, remains well below the current price at 28.60 euros, confirming that the underlying trend has been upward in recent weeks. The RSI, an indicator measuring the momentum of the stock over a recent period, stands at 58, a neutral zone indicating neither overbuying nor overselling. Today's decline occurs amid tensions in European markets: the DAX dropped by 1.58% during the session and the FTSE 100 fell by 0.74%, while the VIX, the American market volatility index, was last measured at 29.49 points, indicating high nervousness.